News Articles Tagged: CNS Treatments

Methyl 6-Methylnicotinate: A Key Intermediate for CNS Disorder Treatments

Explore the synthesis, properties, and critical applications of Methyl 6-Methylnicotinate (CAS 5470-70-2) in treating Central Nervous System disorders. Learn why it's a vital pharmaceutical intermediate.

The Significance of Thiodiglycolic Anhydride in Creating Positively Charged Compounds for Medical Applications

Discover how NINGBO INNO PHARMCHEM CO.,LTD. supplies Thiodiglycolic Anhydride, a key chemical for synthesizing positively charged compounds crucial for pharmaceutical advancements, especially in CNS disorder treatments.

The Role of 2,3-Dichlorobenzoic Acid in Advancing Neurological Therapies

Explore the impact of 2,3-Dichlorobenzoic acid (CAS 50-45-3) on neurological therapies, highlighting its significance as an intermediate in anticonvulsant drugs and its potential in future CNS treatments.